Skip to main content

Table 7 Patients with no neurological symptoms

From: Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database

Patient number/Gender

Sibship

Date of birth

Age at diagnosis

Age at last FU (y, m)/deatha

Neonatal LD

HS/S

Seizures/cataplexy

VSGP

Dev. delay/cognitive problems

Ataxia

Swallowing problems

Psychiatric disturbance

Slurred speech

Genetic mutations

133/M

–

2010

4 m

6 m

Yes

No

No

No

No

No

No

No

–

–

134/M

–

2010

8 m

8 m

Yes

–

–

–

–

–

–

–

–

c.3182 T > C(p.Ile1061Thr)/?

135/M

–

2010

1y

1y

Yes (LTx)

Yes

No

No

No

No

No

No

No

–

136/M

–

2006

6 m

2y 5 m

PJ LD

<4y

No

No

No

No

No

No

No

c.3182 T > C (p.Ile1061Thr)/c.3182 T > C (p.Ile1061Thr)

137/M

–

2003

2y6m

6y 1 m

No

Yes

No

No

No

No

No

No

No

c.3182 T > C (p.Ile1061Thr)/c.3467A > G (p.Asn1156Ser)

138/M

–

2009

4 m

2y 1 m

PJ LD

Yes

No

No

No

No

No

No

No

c.3182 T > C (p.Ile1061Thr)/?

139/M

t

2010

<1y

1y

Yes

Yes

No

No

No

No

No

No

No

c.3182 T > C (p.Ile1061Thr)/c.3289G > A (p.Asp1097Asn)

140/M

t

2006

–

5y

No

No

No

No

No

No

No

No

No

c.3182 T > C (p.Ile1061Thr)/c.3289G > A (p.Asp1097Asn)

141/F

s

1971

1y5m

36y 8 ma

PJ LD

Birth

No

No

Yes

No

No

No

No

c.2336del (p.Phe779SerfsX2)/c.2621A > T (p.Asp874Val)

142/F

–

2008

2y5m

3y

Yes

Yes

No

No

No

No

No

No

No

c.3182 T > C (p.Ile1061Thr)/c.3259 T > C (p.Phe1087Leu)

143/M

–

1987

16y

20y 10 ma

PJ

Birth

No

No

No

No

No

No

No

c.2621A > T (p.Asp874Val)/c.3591 + 4 delA

144/M

–

2007

1y9m

4y

No

Yes

No

No

No

No

No

No

No

–

145/M

–

2009

4 m

2y

Yes

Yes

No

No

No

No

No

No

No

–

146/F

–

2004

7 m

4y 11 ma

PJ

Yes

No

No

No

No

No

–

No

c.3083-3084delP.Gly1028AlafsX22)/c.2201G > T(p.Ser734Ile)

  1. aPatient died; ‘–’, no data/not known; HS/S hepatosplenomegaly/splenomegaly, LD liver disease, LTx liver transplant, m months, PJ prolonged jaundice, y years, w weeks. Note that none of the non-neurological patients had received miglustat by data cut-off end-2011